Back
Larimar Therapeutics, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Sell
46
LRMR
Larimar Therapeutics, Inc.
Last Price:
$3.81
Seasonality Move:
40.5%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LRMR is experiencing slight selling pressure.
Larimar Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.53 | Buy |
| 20-day SMA: | 3.5 | Buy |
| 50-day SMA: | 3.9 | Sell |
| 200-day SMA: | 3.2 | Buy |
| 8-day EMA: | 3.55 | Buy |
| 20-day EMA: | 3.54 | Buy |
| 50-day EMA: | 3.15 | Buy |
| 200-day EMA: | 1.44 | Buy |
Larimar Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 51.7 | Buy |
| Chaikin Money Flow: | -267287 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.35 - 3.71) | Buy |
| Bollinger Bands (100): | (3.45 - 4.31) | Sell |
Larimar Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Larimar Therapeutics, Inc. Stock
Is Larimar Therapeutics, Inc. Stock a Buy?
-
Larimar Therapeutics, Inc. share price is 3.70 while LRMR 8-day simple moving average is 3.53, which is a Buy signal.
-
The stock price of LRMR is 3.70 while Larimar Therapeutics, Inc. 20-day SMA is 3.50, which makes it a Buy.
-
Larimar Therapeutics, Inc. 50-day simple moving average is 3.90 while LRMR share price is 3.70, making it a Sell technically.
-
LRMR stock price is 3.70 and Larimar Therapeutics, Inc. 200-day simple moving average is 3.20, creating a Buy signal.
LRMR Technical Analysis vs Fundamental Analysis
Sell
46
Larimar Therapeutics, Inc. (LRMR)
is a Sell
Is Larimar Therapeutics, Inc. a Buy or a Sell?
-
Larimar Therapeutics, Inc. stock is rated a SellThe current Larimar Therapeutics, Inc. [LRMR] share price is $3.70. The Score for LRMR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Larimar Therapeutics, Inc. Stock Info
Market Cap:
316.7M
Price in USD:
3.70
Share Volume:
623.7K
Larimar Therapeutics, Inc. 52-Week Range
52-Week High:
6.91
52-Week Low:
1.61
Sell
46
Larimar Therapeutics, Inc. (LRMR)
is a Sell
Larimar Therapeutics, Inc. Share Price Forecast
-
What is the Larimar Therapeutics, Inc. stock price today?The Larimar Therapeutics, Inc. stock price is 3.70 USD today.
-
Will LRMR stock go up or go down?Larimar Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Larimar Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Larimar Therapeutics, Inc. is overvalued.
Is Larimar Therapeutics, Inc. Stock a Buy?
-
Larimar Therapeutics, Inc. share price is 3.70 while LRMR 8-day exponential moving average is 3.55, which is a Buy signal.
-
The stock price of LRMR is 3.70 while Larimar Therapeutics, Inc. 20-day EMA is 3.54, which makes it a Buy.
-
Larimar Therapeutics, Inc. 50-day exponential moving average is 3.15 while LRMR share price is 3.70, making it a Buy technically.
-
LRMR stock price is 3.70 and Larimar Therapeutics, Inc. 200-day simple moving average is 1.44, creating a Buy signal.
Fundamental Analysis of Larimar Therapeutics, Inc.
Is Larimar Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and an increase next year of $0.17 per share.
Technical Analysis of Larimar Therapeutics, Inc.
Should I short Larimar Therapeutics, Inc. stock?
-
LRMR Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Larimar Therapeutics, Inc. is a Buy
-
Larimar Therapeutics, Inc. Relative Strength Index (RSI) is 51.7, which suggest Larimar Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Larimar Therapeutics, Inc. is (3.35 - 3.71), which suggest Larimar Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Larimar Therapeutics, Inc. is (3.45 - 4.31), which suggest Larimar Therapeutics, Inc. is a Sell
* Larimar Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.